
11 - 50 employees
Founded 2021
đ§Ź Biotechnology
đŹ Science
đ€ B2B
đ° $45M Series A - Spear Bio on 2024-07
Biotechnology âą Science âą B2B
Spear Bio is a biotechnology company that develops and sells ultra-sensitive protein biomarker detection assays and related reagents and services. Their proprietary SPEAR UltraDetect technology uses a two-factor authenticated, homogeneous (wash-free) format to detect trace protein biomarkers in single-molecule ranges from ultra-small sample volumes, and they offer assay kits (e. g. , pTau217, pTau231, GFAP, NF-L), reaction kits, automation accessories, data analysis, and evaluation/research accelerator services for applications in neurology, immunology, and infectious disease research.
đ 5 days ago
Part-Time Laboratory Director overseeing clinical lab operations at Spear Bio, a biotech startup focused on disease diagnosis.
đ Massachusetts â Remote
đ” $0 - $1 / hour
đ° $45M Series A - Spear Bio on 2024-07
â± Part Time
đŽ Lead
đšââïž Medical Director
đŠ H1B Visa Sponsor
đ February 27
Business Development Manager at Spear Bio introducing ultra-sensitive Immunoassays to the Life Sciences and CRO markets. Seeking candidates with strong neuroscience network on the East or West Coast.
đ Massachusetts â Remote
đ” $150k - $160k / year
đ° $45M Series A - Spear Bio on 2024-07
â° Full Time
đĄ Mid-level
đ Senior
đ° Business Development (BDR)
đŠ H1B Visa Sponsor
đ June 18
Business Development Manager introducing ultra-sensitive Immunoassays to Life Sciences and CRO markets in EMEA. Seeking top talent with a strong network and sales track record.
đȘđș Europe â Remote
đ° $45M Series A - Spear Bio on 2024-07
â° Full Time
đĄ Mid-level
đ Senior
đ° Business Development (BDR)